Over 450 Total Lots Up For Auction at Three Locations - CO 05/12, PA 05/15, NY 05/20

NovaSom, Inc. Launches Next Generation, Industry Leading Cloud-based Obstructive Sleep Apnea Management Platform

Press releases may be edited for formatting or style | November 30, 2011

About NovaSom, Inc.

NovaSom, Inc. is the market leader in obstructive sleep apnea (OSA) home testing, with the first FDA-cleared system and more than 75,000 tests performed to date. It is the manufacturer of NovaSom® HST and second generation AccuSom® HST. Together with its proprietary cloud-based MediTrack® OSA management platform, NovaSom's home sleep testing technology has been shown to provide in-home, clinically equivalent diagnosis of OSA at a significantly reduced cost compared to in-facility sleep testing. Through partnerships with major health insurers, the NovaSom HST is a covered benefit for over 165 million commercially insured lives in the U.S. as of January 1, 2012, and is also approved for Medicare patients.

stats
DOTmed text ad

Your Trusted Source for Sony Medical Displays, Printers & More!

Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.

stats

NovaSom also offers comprehensive service programs that are utilized by payers and physicians nationwide, including its unique Payer Solutions Program that enables health insurers to realize significant cost saving by leveraging proven managed care utilization tools to redirect OSA testing to the home. NovaSom is accredited by the Joint Commission as an Ambulatory Care Sleep Diagnostic Center and is approved by CMS as an Independent Diagnostic Testing Facility. For more information, visit www.NovaSom.com.

Data on file with NovaSom, Inc

Media Contacts

NovaSom, Inc.
Isabel Portieles, 410-590-0443
iportieles@NovaSom.com

The Ruth Group
Lisa Cook, 646-536-7012
lcook@theruthgroup.com

Back to HCB News

You Must Be Logged In To Post A Comment